Low Serum Albumin Is Associated with Poor Prognosis in Patients Receiving Peritoneal Dialysis Treatment

BACKGROUND: The number of patients receiving dialysis treatment is sustainably increasing, especially peritoneal dialysis. OBJECTIVES: It is necessary to find out potential factors that may indicate the prognosis of patients receiving peritoneal dialysis treatment. METHODS: This study retrospectively involved 325 patients who received peritoneal dialysis treatment. RESULTS: Low serum albumin (HR = 2.254; 95% CI: 1.534–3.311; P < 0.001) and high FBG (Fasting blood glucose) (HR = 1.474; 95% CI: 1.025–2.120; P=0.037) were risk factors for death in patients receiving peritoneal dialysis treatment. Serum albumin (AUC = 0.683; P < 0.001) and creatinine (AUC = 0.625; P < 0.001) exhibited value of prognosis prediction. Both high FBG (P=0.005) and low albumin (P < 0.001) were associated with poor prognosis, and low albumin predicted poorer survival. CONCLUSIONS: Low serum albumin and high fasting blood glucose were risk factors and associated with poor prognosis. Low albumin has a potential in predicting the prognosis of patients receiving peritoneal dialysis treatment.